Certolizumab pegol

Details

Files

Generic Name:

Certolizumab pegol

Project Status:

Complete

Therapeutic Area:

Arthritis, rheumatoid

Manufacturer:

UCB Pharma Canada Inc.

Brand Name:

Cimzia

Project Line:

Reimbursement Review

Project Number:

SR0175-000

Submission Type:

Initial

Indications:

Arthritis, rheumatoid

Recommendation Type:

Do not list

Final Recommendation:

May 27, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : September 3, 2009